Innovation Impact

UCalgary researchers, students, postdocs, and staff are making a positive difference in our world. 

University innovation, knowledge engagement and commercialization deliver tangible impact that includes job and new venture creation, product and service sales, and new research opportunities.

It creates economic impact through social and technical advances that lead to new technologies, policies and behaviors, and healthier societies. In Canada, research universities are responsible for 83% of all contracted private-sector research.

Growing innovation at the University of Calgary aligns with federal and provincial Government and City of Calgary strategies for economic growth, builds upon our existing strategies for enhancing the value propositions of the university (Student Experience and Impact), and is derived from our commitment to excellence in Research and Teaching. 

Groundbreaking technology converts waste carbon dioxide

Groundbreaking technology converts waste carbon dioxide

“If our commercial-scale units were to be used by our end users, such as green plastics or petrochemicals producers, we would significantly decrease CO2 emissions — equivalent to removing 100 million cars off the roads or 700,000 jet planes out of the skies,” says Molero. “For every ton of CO2 removed and re-used, three tons of CO2 emissions are eliminated.”

Read more

From goth to deadly fungal infections: undergrad research

From goth to deadly fungal infections: undergrad research

“I’ve personally learned a lot about myself,” says Emilie Medland-Marchen, reflecting on her experiences last summer as a recipient of a Program for Undergraduate Research Experience (PURE) Award at the University of Calgary. “I think a lot of arts students have a tendency to shy away from this kind of funding because they have this idea that it normally goes to science students, or engineering or medical students, but I think it is really important to take on these research opportunities.”

Read more

Peter Facchini

Willow Biosciences synthesizing safer pain medications

Research led by biochemist Peter Facchini widens path to microbial production of pharmaceutical opiates

 

Read more

Treatment for autoimmune diseases takes a step forward

Parvus Therapeutics announces worldwide collaboration and licence agreement with Genentech to develop and commercialize Navacim therapeutics.

 

Read more
Colin Dalton and Pierre Wijdenes

Neuraura aims to unlock the brain with next-gen microsensors

Neuraura Biotech’s vision is big and bold—to unlock the brain. The Calgary-based company has developed a novel microsensor that monitors brain activity better than ever before. The result could change the way technology is used to improve the lives of people suffering from neurological, psychiatric and sensory conditions.

Read more